Malaria Rapid Diagnostic Tests (RDTS)
Market Projected to Surpass US$ 726.9M by
2033
New York, NY – June 19, 2025 - The global Malaria Rapid Diagnostic Tests (RDTs) market
is expected to reach US$ 726.9 Million by 2033, up from US$ 442.0 Million in 2023. This
growth is projected at a steady CAGR of 5.1% during the forecast period from 2024 to 2033.
One of the major factors driving this market is the rising number of malaria cases, especially
in low- and middle-income countries. Malaria remains a major health challenge in Africa,
Southeast Asia, and parts of South America. As the disease continues to spread in these
regions, the demand for quick and reliable diagnostic tools is increasing rapidly.
A key growth factor for the RDT market is strong support from international health
organizations and national governments. Agencies such as the World Health Organization
(WHO), UNICEF, and the U.S. President’s Malaria Initiative (PMI) are actively working to
improve access to diagnostic testing. These efforts often involve distributing RDTs for free or
at subsidized prices. The Global Fund is another major organization helping to fund these
initiatives. These large-scale programs help to make testing available in remote and
underserved areas, which boosts the usage of RDTs and expands market reach.
The shift in healthcare guidelines is also influencing market growth. The WHO now
recommends that all suspected malaria cases be confirmed with a diagnostic test before
treatment begins. This change supports the move from presumptive treatment to evidencebased treatment. As a result, healthcare workers are using more RDTs in both public and
private health settings. The goal is to reduce unnecessary drug use and ensure accurate
diagnosis. This shift in treatment practices is increasing demand for reliable and easy-to-use
testing kits.
Technology improvements in RDTs are making them more effective and appealing. Newer
malaria RDTs offer better sensitivity and can detect multiple malaria species. This is
important in areas where more than one type of parasite may be present. These advancements
improve diagnosis accuracy, reduce misdiagnosis, and build trust in healthcare services. In
addition, these tests do not require electricity or complex lab equipment, making them
suitable for use in low-resource settings. Their portability and simplicity add to their value in
community-based health programs.
Key Takeaways







Strong Market Growth Expected : An expert notes the malaria RDT market is
projected to hit US$ 726.9 Million by 2033, growing from US$ 442 Million in 2023.
Consistent CAGR Drives Market Forward : Between 2024 and 2033, the market is
expected to grow steadily at a compound annual growth rate (CAGR) of 5.1%.
Single Species Detection Leads the Segment : Industry insiders highlight that single
species detection tests dominate with a commanding 61.1% share of the overall RDT
market.
Hospitals Take the Lead in End-Use : Hospitals continue to be the top users of
malaria RDTs, accounting for a substantial 54% of the global market share.
Asia-Pacific Region Dominates Regionally : The APAC region holds the largest
share at 36.4%, translating to a market value of approximately US$ 160.2 Million in
2023.
Technology Enhancements Boost Test Accuracy : Advances in RDT technology are
improving sensitivity and specificity, offering better support for timely malaria
detection and treatment.
Government Backing Fuels Adoption Rates : Governments worldwide are ramping up
support through policies and funding to drive the widespread use of RDTs in malaria
control efforts.
Emerging Trends
Focus on Detecting Multiple Malaria Species
New RDTs are now able to detect more than one type of malaria in a single test. These tests
can identify both Plasmodium falciparum (the most dangerous form) and Plasmodium vivax
(common in Asia and Latin America). This is important because it helps doctors give the
right medicine quickly. Quick and accurate detection saves lives and prevents complications.
Multi-species detection is especially helpful in regions with mixed infections. It also supports
global efforts to monitor how malaria types are spreading. As a result, healthcare providers
can act faster and stop the disease from getting worse.
Improved Sensitivity in Low Transmission Areas
In places where malaria cases are now rare, detecting the disease early is crucial. New RDTs
are more sensitive and can find very low levels of the malaria parasite. This means they can
catch infections that might have gone unnoticed before. Early detection helps stop the disease
from spreading again in areas close to eliminating malaria. These highly sensitive tests
support health workers during routine checkups and surveys. They are a key part of keeping
malaria under control. With better tools, health teams can respond quickly and keep the
disease from coming back.
Heat-Stable RDTs for Tropical Regions
Many malaria-endemic areas are hot and humid. Traditional tests often get damaged in such
environments. Now, heat-stable malaria RDTs are available. These can withstand high
temperatures and still give accurate results. This is especially useful in remote areas where
electricity and proper storage are limited. Heat-stable RDTs make sure test results remain
reliable, even in tough conditions. This helps healthcare workers diagnose patients correctly
the first time. They also reduce waste, as fewer tests are spoiled by heat. These improvements
are making RDTs more practical for real-world use in tropical countries.
Digital and Smartphone Integration
Some modern RDTs can now connect with mobile apps or digital devices. These tools help
healthcare workers store and share test results in real time. It speeds up reporting and makes
malaria tracking more efficient. With digital integration, test results can be sent directly to
national health systems. This helps leaders make quick decisions and plan better malaria
responses. It also improves transparency and accountability in health programs. Smartphonebased readers are easy to use in the field. They are helping frontline workers provide better
care and collect data accurately.
Use Cases
Quick Diagnosis in Rural Clinics
Malaria RDTs are a lifesaver in rural health centers that don’t have labs. A nurse or health
worker can perform the test using just a drop of blood. The results are ready in 15 to 20
minutes. This quick process helps doctors start treatment immediately. In remote areas, early
diagnosis is key to preventing serious illness. Without RDTs, patients might need to travel
long distances for testing. That delay could be dangerous. Using RDTs on-site ensures
patients get the right care on time. It also reduces pressure on referral hospitals and helps
improve survival rates in low-resource settings.
Screening During Malaria Outbreaks
During a malaria outbreak, it's important to act fast. RDTs help health teams test many people
quickly. They can identify infected patients early and prevent the disease from spreading
further. With faster results, people who test positive can start treatment right away. This also
helps protect their family members and neighbors. RDTs are easy to use and don’t need any
special lab equipment. That makes them perfect for emergency response during outbreaks.
Health officials can also use test data to map the spread of the disease. This helps target
control efforts in the most affected areas.
Emergency Use in Conflict or Disaster Zones
In war zones, disaster-hit areas, or refugee camps, healthcare is often hard to access. RDTs
provide a fast and simple solution for diagnosing malaria in these emergency settings. Health
workers don’t need labs or electricity. Just a small blood sample is enough. Within minutes,
they can tell if someone has malaria. This is critical in saving lives, especially when hospital
care is limited. Quick diagnosis helps prevent severe illness or death. RDTs can be packed
and transported easily. That makes them ideal for mobile health units operating in unstable
areas.
Use by Community Health Volunteers
In remote villages, trained community health volunteers play a big role in fighting malaria.
They visit homes and use RDTs to test people with symptoms. This is vital for those who
can’t reach clinics due to distance, lack of transport, or cost. Volunteers help catch malaria
early before it becomes severe. They can also educate families on how to prevent mosquito
bites. Using RDTs in the field brings healthcare to the doorstep. It reduces the burden on
hospitals and ensures faster treatment. This grassroots approach is key in reaching
underserved populations and controlling malaria locally.
Monitoring and Surveillance Programs
Public health programs rely on data to track malaria cases. RDTs make it easier to gather this
data in real time. Health workers can test patients, log results, and send the information to
central databases. This helps health officials understand where malaria is spreading and how
fast. It also shows whether control programs are working. In some regions, this data guides
decisions about where to send extra resources or launch prevention campaigns. Using RDTs
for monitoring helps countries move closer to malaria elimination goals. The tests are lowcost, reliable, and perfect for large-scale health reporting.
Conclusion
In conclusion, the market for malaria rapid diagnostic tests is growing due to strong global
health efforts and better technology. These tests are now faster, more accurate, and easier to
use in all types of settings, from rural clinics to emergency zones. Support from governments
and international health organizations is also helping increase access to testing, especially in
places where malaria is common. More health workers are using RDTs to confirm cases
quickly and provide timely treatment. As healthcare guidelines continue to promote testing
before treatment, the demand for these tools will keep rising. Malaria RDTs are becoming a
vital part of global efforts to control and eventually eliminate the disease.